Vivos Therapeutics Inc

NASDAQ:VVOS   3:59:42 PM EDT
6.15
-0.25 (-3.91%)
Earnings Announcements

Vivos Therapeutics Reports Fourth Quarter And Full Year 2020 Financial Results And Operational Update

Published: 03/25/2021 20:22 GMT
Vivos Therapeutics Inc (VVOS) - Vivos Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update.
Q4 Revenue $3.3 Million Versus $3.1 Million.
Cash and Cash Equivalents Were $18.2 Million at December 31, 2020.
Revenue is expected to be $3.25 Million
Adjusted EPS is expected to be -$0.17

Next Quarter Revenue Guidance is expected to be $3.58 Million
Next Quarter EPS Guidance is expected to be -$0.18

More details on our Analysts Page.